Results 11 to 20 of about 7,356,650 (144)
Individualized controlled ovarian stimulation in expected poor-responders: an update
Reproductive Biology and Endocrinology, 2018 Controlled ovarian stimulation with subsequent multi-follicular development continues to be a keystone in ART. Evidence supports an individualized approach to ovarian stimulation, usually involving combinations of ovarian reserve tests, body mass index ...
Thor Haahr +2 more
doaj +2 more sources
Journal of Human Reproductive Sciences, 2012 Objectives: (a) To establish the cut-off levels for anti-Mullerian hormone (AMH) in a population of Indian women that would determine poor response. (b) To determine which among the three ie.,: age, follicle stimulating hormone (FSH), or AMH, is the ...
Ruma Satwik +3 more
doaj +2 more sources
Mild Ovarian Stimulation Strategy versus conventional ovarian Stimulation in Poor Responder Women Undergoing ICSI [PDF]
Minia Journal of Medical Research, 2020 Introduction: One of the most frustrating problems in IVF today is the low pregnancy rate in women with poor ovarian response (Webb et al., 2016). Poor responders are estimated to comprise approximately 9-24% of IVF/ICSI patients (Papathanasiou et al ...
Abd EL-Rahman Abd El-Wahab +3 more
doaj +1 more source
BMC Women's Health, 2022 Objective To explore the efficacy of progestin-primed ovarian stimulation (PPOS) combined with clomiphene citrate (CC) versus PPOS protocol used alone on cycle characteristics and pregnancy outcomes for women with the poor ovarian response (POR). Methods
Ahui Liu +5 more
doaj +1 more source
Middle East Fertility Society Journal, 2021 Background Prediction of ovarian response prior to the ovarian stimulation cycle is useful in determining the optimal starting dose of recombinant follicle-stimulating hormone (r-FSH).
Mohammed M. Laqqan, Maged M. Yassin
doaj +1 more source
Frontiers in Endocrinology, 2023 BackgroundReliable predictive models for predicting excessive and poor ovarian response in controlled ovarian stimulation (COS) is currently lacking. The dynamic (Δ) inhibin B, which refers to increment of inhibin B responding to exogenous gonadotropin ...
Congcong Ma +24 more
doaj +1 more source
Tumour-associated immune responses and isolated carcinoembryonic antigen and alpha feto-protein levels related to survival in ovarian cancer patients. [PDF]
, 1976 The presence of a tumour-associated immune response in 37 patients with ovarian cancer as assessed by blastogenesis (lymphocyte transformation) evoked by ovarian cancer cell extracts, has been correlated with survival following the test.
Levin, L +6 more
core +3 more sources
Journal of Human Reproductive Sciences, 2010 Background: Ovarian response varies considerably among individuals and depends on various factors. Poor response in IVF yields lesser oocytes and is associated with poorer pregnancy perspective.
Nabaneeta Padhy +4 more
doaj +1 more source
The effects of anti-IL-6 therapy in advanced ovarian cancer [PDF]
, 2010 PhDIL-6 is a pleiotropic cytokine that has a significant role in inflammatory processes. In relation to ovarian cancer biology there is emerging evidence that it mediates processes relating to tumour growth, invasion, angiogenesis and chemo-resistance ...
Coward, Jermaine
core +2 more sources
Frontiers in Endocrinology, 2018 Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation present a challenge for reproductive specialists.
Sandro C. Esteves +8 more
doaj +1 more source